by Oscar Jofre | Mar 11, 2022 | KoreConX
Joseph C. McGinley. M.D., Ph.D. is a highly accomplished musculoskeletal intervention and sports medicine physician with over 15 years of experience in the field. He holds a Bachelor’s and Master’s Degree in Mechanical Engineering and a Ph.D. in Physiology...
by Oscar Jofre | Mar 2, 2022 | KoreConX
Working at Facible, Brent Fawson believes that the company is poised to leave a lasting impact on lives around the world by making medical diagnostic testing more accessible. We sat down with Brent and talked to him about the medical industry, his company, and capital...
by Oscar Jofre | Feb 28, 2022 | KoreConX
Founders and executives of startup and early-stage healthcare companies seeking funding historically were limited to appeals to Venture Capital firms, Angels, and bootstrapping – struggling to survive by internal growth alone. In many cases, the founders resort...
by Oscar Jofre | Feb 23, 2022 | Capital Markets, KoreConX, KorePartner, News Releases
Experts in the life sciences sector will teach investors how to use Regulation A+ for successful capital raising NEW YORK, February 23, 2022 – KoreConX is thrilled to announce its participation at LSI Emerging Medtech Summit – USA 2022. This event...
by Oscar Jofre | Feb 21, 2022 | KoreConX
This article was written by Erin Holloway, KorePartner from Prime Trust. It was originally published on Crowdfund Insider, view the original article here. Investment crowdfunding took off when the JOBS Act regulation went into effect back in 2016 and has become...
by Oscar Jofre | Feb 16, 2022 | KoreConX
When companies begin the capital raising journey, it is no longer about going public or simply getting a company’s product in front of venture capitalists. To be successful in our current capital raising landscape with Regulations A+ and CF, organizations must...
